KEI Comments on NIH Exclusive License to Ridgeback for FDA-approved Ebola Treatment

On March 30, 2021, Knowledge Ecology International (KEI) filed comments regarding the National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID), “Prospective Grant of an Exclusive Patent License: Development, Production, and Commercialization of Ebola Neutralizing Single… Continue Reading